Ingen Technologies, Inc. (IGNT)
OTCMKTS · Delayed Price · Currency is USD
0.000007
0.00 (0.00%)
At close: Sep 17, 2026
Ingen Technologies Revenue
In the fiscal year ending May 31, 2015, Ingen Technologies had annual revenue of $13.57K with 1.14% growth. Ingen Technologies had revenue of $3.38K in the quarter ending May 31, 2012, a decrease of -67.86%.
Revenue
13.57K
Revenue Growth
-70.89%
P/S Ratio
n/a
Revenue / Employee
2.71K
Employees
5
Market Cap
n/a
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2015 | 13.57K | 153.00 | 1.14% |
| May 31, 2012 | 13.41K | -30.96K | -69.77% |
| May 31, 2011 | 44.37K | -84.55K | -65.58% |
| May 31, 2010 | 128.92K | 118.52K | 1,139.47% |
| May 31, 2009 | 10.40K | -242.09K | -95.88% |
| May 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 36.88M |
| Sonendo | 31.70M |
| Kelyniam Global | 2.67M |
| BioElectronics | 1.61M |
| PetVivo Holdings | 1.18M |
| Guided Therapeutics | 650.00K |
| Positron | 444.82K |
| Vivos | 99.10K |